ELIA, Maria
 Distribuzione geografica
Continente #
NA - Nord America 199
AS - Asia 132
EU - Europa 105
SA - Sud America 46
AF - Africa 6
Totale 488
Nazione #
US - Stati Uniti d'America 193
SG - Singapore 62
IT - Italia 42
BR - Brasile 36
CN - Cina 19
DE - Germania 19
IN - India 17
VN - Vietnam 16
SE - Svezia 9
GB - Regno Unito 7
HK - Hong Kong 7
UA - Ucraina 6
AR - Argentina 4
EE - Estonia 4
FI - Finlandia 4
ZA - Sudafrica 4
CA - Canada 3
ES - Italia 3
TR - Turchia 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
FR - Francia 2
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
RU - Federazione Russa 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BB - Barbados 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LT - Lituania 1
PK - Pakistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 488
Città #
Singapore 43
Dallas 29
Chandler 25
Munich 16
Bengaluru 14
Hefei 14
Milan 12
Ho Chi Minh City 11
Lawrence 10
Princeton 10
Santa Clara 10
Ashburn 7
Hong Kong 7
London 6
Cetraro 5
Brooklyn 4
Chicago 4
Los Angeles 4
Crosia 3
Des Moines 3
Stockholm 3
Turku 3
Valmadrera 3
Wilmington 3
Atlanta 2
Cortona 2
Greensboro 2
Hanoi 2
Melegnano 2
New York 2
Nicotera 2
Olomouc 2
Osaka 2
Osasco 2
Pretoria 2
Rio de Janeiro 2
San Jose 2
Strasbourg 2
São Paulo 2
Toronto 2
Tunis 2
Akron 1
Amsterdam 1
Ankara 1
Baghdad 1
Biên Hòa 1
Blumenau 1
Boardman 1
Bologna 1
Brakpan 1
Brasília 1
Bridgetown 1
Bắc Giang 1
Candelária 1
Canela 1
Cassano d'Adda 1
Caçapava 1
Chennai 1
Contagem 1
Corrientes 1
Denver 1
Dhaka 1
Dubai 1
General Salgado 1
Gravataí 1
Greenwood 1
Guangzhou 1
Guarujá 1
Guayaquil 1
Helsinki 1
Hualpén 1
Itaúna 1
Jaboatão dos Guararapes 1
Jakarta 1
Jaíba 1
Jinan 1
Johannesburg 1
Kemerovo 1
La Paz 1
Lahore 1
Lebon Régis 1
Linhares 1
Luziânia 1
Madrid 1
Marília 1
Merlo 1
Montague 1
Montevideo 1
Mountain View 1
Mumbai 1
Muğla 1
Naples 1
Natal 1
Neath 1
New Delhi 1
Northampton 1
Norwalk 1
Nuremberg 1
Pau dos Ferros 1
Paulo Afonso 1
Totale 342
Nome #
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 67
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy 45
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: Insights fromthe EYESHOT study 41
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording 41
Connectivity measures suggest a sub-cortical generator of myoclonus in Angelman syndrome 39
Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 39
Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications 34
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 33
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 32
Epilepsy, electroclinical features, and long-term outcomes in Pitt–Hopkins syndrome due to pathogenic variants in the TCF4 gene 30
Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox–Gastaut syndrome: A prospective observational clinical study 28
From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We? 27
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations 27
Perampanel tolerability in children and adolescents with focal epilepsy: Effects on behavior and executive functions 26
Totale 509
Categoria #
all - tutte 5.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 6 0 1 2 7 3 0 0 0
2021/202238 0 0 0 5 1 0 5 4 11 4 7 1
2022/202376 20 2 10 3 7 5 0 3 7 8 9 2
2023/202436 11 6 2 6 2 5 0 0 0 1 2 1
2024/2025156 20 1 2 1 7 21 7 2 14 4 21 56
2025/2026183 29 39 71 44 0 0 0 0 0 0 0 0
Totale 509